Mr. Mark B. Kaye's most recent trade in Elevance Health Inc was a trade of 4,161 shares done at an average price of $386.4 . Disclosure was reported to the exchange on Oct. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.43 per share. | 02 Oct 2026 | 4,161 | 27,876 (0%) | 0% | 386.4 | 1,607,935 | - |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2026 | 2,627 | 30,503 (0%) | 0% | 0 | - | |
| Conmed Corp | Mr. Mark B. Kaye | Director | 01 Jun 2026 | 5,772 | 5,772 | - | - | RSUs (Restricted Stock Units) | ||
| Conmed Corp | Mr. Mark B. Kaye | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 668 | 820 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp | Mr. Mark B. Kaye | Director | 01 Jun 2026 | 668 | 0 | - | - | RSUs (Restricted Stock Units) | ||
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | 02 Mar 2026 | 25,188 | 25,188 | - | - | Employee Stock Option (Right to Buy) | ||
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 10,202 | 32,390 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 6,377 | 22,188 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 284.03 per share. | 02 Mar 2026 | 353 | 32,037 (0%) | 0% | 284.0 | 100,263 | Common Stock |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 294.07 per share. | 02 Mar 2026 | 271 | 15,811 (0%) | 0% | 294.1 | 79,693 | Common Stock |
| Conmed Corp | Mr. Mark B. Kaye | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2026 | 152 | 152 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp | Mr. Mark B. Kaye | Director | 24 Feb 2026 | 152 | 0 | - | - | RSUs (Restricted Stock Units) | ||
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 340.24 per share. | 02 Oct 2025 | 2,895 | 16,082 (0%) | 0% | 340.2 | 984,995 | Common Stock |
| Conmed Corp | Mr. Mark B. Kaye | Director | 02 Jun 2025 | 8,061 | 8,061 | - | - | Options To Purchase Common Stock | ||
| Conmed Corp | Mr. Mark B. Kaye | Director | 02 Jun 2025 | 668 | 668 | - | - | RSUs (Restricted Stock Units) | ||
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Sale of securities on an exchange or to another person at price $ 424.82 per share. | 24 Apr 2025 | 4,588 | 18,977 (0%) | 0% | 424.8 | 1,949,074 | Common Stock |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | 03 Mar 2025 | 13,713 | 13,713 | - | - | Employee Stock Option (Right to Buy) | ||
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,604 | 23,565 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 270 | 19,961 (0%) | 0% | 395.5 | 106,785 | Common Stock |
| Conmed Corp | Mr. Mark B. Kaye | Director | 24 Feb 2025 | 1,846 | 1,846 | - | - | Options To Purchase Common Stock | ||
| Conmed Corp | Mr. Mark B. Kaye | Director | 24 Feb 2025 | 152 | 152 | - | - | RSUs (Restricted Stock Units) | ||
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 505.16 per share. | 02 Oct 2024 | 2,818 | 20,213 (0%) | 0% | 505.2 | 1,423,541 | Common Stock |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | 01 Mar 2024 | 10,633 | 10,633 | - | - | Employee Stock Option (Right to Buy) | ||
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,755 | 23,031 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 18,174 | 18,174 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO Designate | 02 Oct 2023 | 8,076 | 8,076 | - | - | Employee Stock Option (Right to Buy) | ||
| Elevance Health | Mr. Mark B. Kaye | EVP & CFO Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 2,102 | 20,276 (0%) | 0% | 0 | Common Stock |